Twenty-eight patients initially had metastases, 148 of the 283 patients who initially had early breast cancer relapsed (137 and 11 with wild-type and AKT1 mutations, respectively), and 48 died of breast cancer. The gene discussed is AKT1; the disease is breast cancer.